Projects (12573)
Cardiff University Schools involved in this Project
Targeting neuroinflammation in mTORC1 driven brain tumours (01/10/2019 - 31/05/2023)
- Tee, Andrew
Targeting NF-xB activation and proliferation signals in CLL (01/11/2013 - 31/07/2018)
- Pepper, Christopher
- Targeting novel anti-complement drugs to the brain for therapy of
dementia. (01/10/2021 - 31/12/2026)- Zelek, Wioleta
Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01/10/2016 - 15/11/2018)
- Brancale, Andrea
Targeting Ref1/STAT3 to treat Tuberous Sclerosis (01/04/2018 - 09/02/2023)
- Tee, Andrew
Targeting the allosteric control of alarmone synthetases to tackle bacteria persistence (01/10/2017 - 15/01/2020)
- Jin, Yi
Targeting the CD8 coreceptor as a novel strategy for the treatment of type 1 diabetes (01/01/2013 - 31/12/2013)
Targeting the early endosome as a therapeutic strategy in neurodegenerative diseases (01/01/2024 - 14/04/2027)
- Connor-Robson, Natalie
Targeting the pathological pathways to Parkinson's (02/05/2018 - 01/08/2021)
- Webber, Caleb
Targeting the terminal pathway in complement - driven disease (30/06/2018 - 30/09/2018)
- Morgan, Paul